SCHEMBL31377351

SCHEMBL31377351

CC(=O)O[C@H]1[C@@H](Cc2ccc(-c3ccccc3)cc2)N(C(=O)OC(C)(C)C)C[C@@H]1O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 3/20 0.40
▸ NR1H3 Q13133 3/20 0.40
▸ DPP4 P27487 1/20 0.39
▸ USP30 Q70CQ3 2/20 0.39
▸ TACR1 P25103 3/20 0.37
▸ RXRA P19793 1/20 0.37
▸ MCL1 Q07820 3/20 0.36
▸ CYP2D6 P10635 3/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SLC2A1 P11166 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31377178 0.94 NR1H2 (0.45) NR1H2NR1H3DPP4TACR1
SCHEMBL31377211 0.94 NR1H2 (0.45) NR1H2NR1H3DPP4TACR1
SCHEMBL31377105 0.88 CYP2D6 (0.38) NR1H2NR1H3TACR1CYP2D6SMN1; SMN2
SCHEMBL31420706 0.88 DPP4 (0.40) NR1H2NR1H3DPP4USP30TACR1
SCHEMBL31377193 0.87 VEGFA (0.38) NR1H2NR1H3CYP2D6SMN1; SMN2LMNA
SCHEMBL31377217 0.87 RORC (0.38) NR1H2NR1H3CYP2D6SMN1; SMN2LMNA
SCHEMBL31377297 0.86 SMN1; SMN2 (0.51) CYP2D6SMN1; SMN2LMNAMAPK1HIF1A
SCHEMBL31377102 0.84 CYP2D6 (0.35) NR1H2NR1H3TACR1CYP2D6SMN1; SMN2
SCHEMBL31377384 0.84 AR (0.43) NR1H2NR1H3DPP4CYP2D6SMN1; SMN2
SCHEMBL31421470 0.84 GPR119 (0.40) USP30CYP2D6SMN1; SMN2LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025064683-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-27 — — WO disclosed
US-20250091989-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091989-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, NRAS NR1H2 3045/4885NR1H3 3249/4885DPP4 4722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback